Etsuo Kawada
About
In The Last Decade
Etsuo Kawada
22 papers receiving 378 citations
Peers
Comparison fields: 5 of 103
- Materials Chemistry 175
- Biomedical Engineering 98
- Biomaterials 45
- Neurology 40
- Pathology and Forensic Medicine 35
Countries citing papers authored by Etsuo Kawada
This map shows the geographic impact of Etsuo Kawada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Etsuo Kawada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Etsuo Kawada more than expected).
Fields of papers citing papers by Etsuo Kawada
This network shows the impact of papers produced by Etsuo Kawada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Etsuo Kawada. The network helps show where Etsuo Kawada may publish in the future.
Co-authorship network of co-authors of Etsuo Kawada
This figure shows the co-authorship network connecting the top 25 collaborators of Etsuo Kawada. A scholar is included among the top collaborators of Etsuo Kawada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Etsuo Kawada. Etsuo Kawada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 3 | |
| 6 | 44 | |
| 7 | 1 | |
| 8 | 6 | |
| 9 | 1 | |
| 10 | [A case of adult idiopathic thrombocytopenic purpura associated with atypical mumps virus infection]. | 1 |
| 11 | 9 | |
| 12 | 4 | |
| 13 | Decrease in serum ferritin level in a patient with HCV hepatitis and liver hemosiderosis by interferon-alpha. | 1 |
| 14 | [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders]. | 1 |
| 15 | 36 | |
| 16 | 8 | |
| 17 | A long-term survivor with malignant thymoma accompanied with pure red cell aplasia. | 2 |
| 18 | 4 | |
| 19 | 3 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.